Lind Global Fund II LP 13D and 13G filings for PaxMedica, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:10 pm Sale | 2024-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 985,000 9.900% | -23,599 (-2.34%) | Filing |
| 2024-11-14 7:22 pm Purchase | 2024-09-30 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 1,008,599 8.800% | 756,829 (+300.60%) | Filing |
| 2024-02-13 8:11 pm Purchase | 2023-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 251,770 9.900% | 251,770 (New Position) | Filing |